Shree Ram Proteins Limited Holds 17th AGM on March 5, 2026, Approves Financials and Director Appointments
Shree Ram Proteins Limited held its 17th AGM on March 5, 2026. Key resolutions included adopting FY25 financials, appointing directors, increasing authorized share capital, and appointing secretarial auditors for five years. The board also received authority to borrow money.
The event is a standard annual general meeting, which is a routine corporate compliance activity. The outcomes, such as director appointments and financial statement adoption, are expected and do not indicate any significant deviation or new development impacting the company's operations or market position.
The announcement details routine corporate governance procedures like the AGM, director appointments, and financial statement adoption. It does not contain any significant positive or negative financial performance indicators or strategic shifts.
Shree Ram Proteins Limited conducted its 17th Annual General Meeting (AGM) on Thursday, March 5, 2026, through video conferencing and other audio-visual means. The meeting, which commenced at 2:02 PM IST and concluded at 2:08 PM, was held in compliance with circulars from the Ministry of Corporate Affairs (MCA) and SEBI.
The AGM focused on several key business items, including the adoption of the audited financial statements for the financial year ended March 31, 2025, along with the reports of the Board of Directors and Auditors. Resolutions were passed to appoint directors, increase the authorized share capital, and regularize additional directors, Ms. Naaz Jaiswal and Mr. Jayvir Vajubhai Kuvadiya, as independent directors. Furthermore, M/s. Payal Dhamecha & Associates were appointed as Secretarial Auditors for a five-year term from FY 2025-26 to FY 2029-30, and their remuneration was ratified. The company also sought authority for the Board to borrow money exceeding paid-up share capital and free reserves, as per Section 180(1)(c) of the Companies Act, 2013, and addressed matters specified under Section 180(1)(a).
During the meeting, the Chairman, Mr. Lalitkumar Chandulal Vasoya, welcomed the members and presented an overview of the company's financial performance, achievements, and future plans. The Chief Financial Officer, Mr. Krutil Kishorbhai Parakhia, provided detailed insights into the financial performance for FY 2024-25. The proceedings also included discussions on the auditor's report and the notice convening the meeting. The combined results of the e-voting and voting during the AGM will be announced and submitted to the stock exchanges.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.